嘉    宾： 刘晨源 助理教授 清华大学

主持人： 薛沁舒 助理教授 上海交通大学安泰经济与管理学院

时    间：2025年10月22日（周三）14:00-15:30

地    点:  上海交通大学徐汇校区安泰经济与管理学院B201

内容简介：

How can developing countries foster pharmaceutical innovation when drug price negotiations risk eroding firms’ incentives? China’s National Health Insurance Drug Price Negotiation addresses this challenge by pairing substantial price cuts with expanded insurance coverage for innovative drugs, enlarging the effective market size. We examine its impact on innovation using a difference-in-differences design that compares clinical trials for new drugs (treated) to those for vaccines (unaffected). The policy increases the number of trials by 0.77 per disease per year. The effects are especially pronounced for more novel innovations and similar for domestic and foreign firms. We also find that the policy induces more R&D pharmaceutical firms to enter the market, and the effects exist for both firms conducting clinical trials and drug licensing, and firms only specializing in clinical trials.

演讲人简介：

刘晨源，清华大学经济与管理学院经济系助理教授。曾获得香港大学经济学学士、美国威斯康星大学风险管理与保险博士学位。她曾获得国家自然科学基金青年项目资助，研究成果发表于American Economic Journal: Economic Policy、Journal of Health Economics等期刊。

欢迎广大师生参加！